Clinical trial evaluates first-line approaches for treating HIV
...than the three-drug combination of two NRTIs and a protease inhibitor called lopinavir/ritonavir. Moreover, a ...se a general belief that combining an NNRTI with a protease inhibitor could result in resistance to two important classes of drugs. But earlier studies with oth...Study shows promise for simplified treatment of HIV infection
...minary study indicates that using a single boosted protease inhibitor instead of the standard regimen of 3 dru...ssion for 48 weeks or longer receiving their first protease inhibitor (PI)based regimen. Participants switched PIs to atazanavir-ritonavir at entry and disconti...Panel updates guidelines for treatment of adult HIV infection
...oside reverse transcriptase inhibitor (NNRTI) or a protease inhibitor (PI) boosted with low-dose ritonavir. Given the high degree of comparability of the recommended components of these regimens in treatment-naive persons with drug-susceptible virus, the choice of regimen centers on acceptability; predicted t...Updated International AIDS Society guidelines recommend new goal of undetectable viral load
...ncy of at least two active drugs such as a boosted protease inhibitor (darunavir) and a drug with a new mechanism of action (such as FUZEON) added to a background of an optimised antiretroviral regimen. This strategy is not only recommended by the IAS-US panel guidelines published this week but also by the US...HIV drug could be used to prevent cervical cancer, say University of Manchester researchers
...pe of drug that is given orally to treat HIV. This protease inhibitor can selectively kill cultured HPV infected cervical cancer cells and, since it is already available as a liquid formulation, it is possible it may work by direct application to the cervix. The research, funded by the Humane Research Trust...New path from estrogen to survival in breast cancer cells described
...other proteins and alter their function. SENP8, a protease (enzyme) that can break bonds between other molecules. SIRT1 NFkB (Nuclear Factor kappa B), a family of proteins that turn on genes involved in cell death (apoptosis) and cell proliferation. When over-expressed, NFkB can protect cells from undergoing...Tibotec Therapeutics announces start of largest US study on HIV treatment in women
...hose with HIV-1 strains resistant to more than one protease inhibitor. PREZISTA received accelerated approval...erance or failure to prior therapy consisting of a protease inhibitor and/or non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral t...Darunavir with FUZEON provides HIV patients a better chance to reach undetectable viral load
... Products for Human Use (CHMP) of Tibotecs boosted protease inhibitor darunavir is good news for HIV treatment...e of FUZEON with an active agent such as a boosted protease inhibitor is acknowledged in the guidelines as one of the best way to achieve undetectable viral loa...Response to anti-HIV therapy improved if treatment begins six months after preventive regimen
...ug combinations usually include the more expensive protease inhibitors, instead of nevirapine. "The findings show that single dose nevirapine during labor alone--or with short course AZT during pregnancy--remains a viable option in resource-poor settings for preventing the spread of HIV from mother to child ...New class of HIV drug attacks previously untargeted enzyme
...cessful replication of HIV reverse-transcriptase, protease and integrase. Integrase is responsible for insert... target enzymes have been reverse-transcriptase or protease inhibitors. Dr Bach-Yen Nguyen, Merck Research Laboratories, Westpoint, Pennsylvania, USA, and col...Resistant HIV quickly hides in infants' cells
...ll bad: a different class of antiretroviral drugs, protease inhibitors (PIs), was effective in controlling HIV viral load and NNRTI-resistant virus strains for all infants studied. These findings have important implications when it comes to choosing among available treatments. As Persaud summarized, "The i...Commercializing university research -- Hopping robots, liquid shoes, electricity from heat
...Disease Diagnostics."The team is proposing a novel protease activity detection system for the monitoring of clinically relevant inflammatory responses and for disease diagnosis. The project will involve the development of nanoparticle labeled substrates which can be used in micro and nanoarray, microfluidic, ...Scripps Research awarded $17 million for adult stem cell use to treat eye diseases
...or cells; from the Ruf lab in vascular endothelial protease and protease activated receptor signaling; from the Nemerow and Siuzdak groups in molecular tools for the modific...Study finds HIV protease inhibitor drugs may adversely affect the scaffolding of the cell nucleus
...from Purdue University, have demonstrated that HIV protease inhibitors crucial drugs for HIV treatment block...gs may offer insights into the side effects of HIV protease inhibitors, including metabolic syndrome and regional losses of some of the bodys fat tissue. These...